Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Trends in Cardiovascular Medicine|August 16, 2005
The role of high-density lipoprotein in inflammationMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Current Opinion in Lipidology|July 29, 2024
Evidence further linking the intestine to cardiovascular diseaseDawoud Sulaiman, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 27, 2023
The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosisArnab Chattopadhyay, Srinivasa T Reddy, Alan M Fogelman
Nature Reviews. Nephrology|March 24, 2010
HDL metabolism and activity in chronic kidney diseaseNosratola D Vaziri, Mohamad Navab, Alan M Fogelman
Trends in Cardiovascular Medicine|March 1, 2008
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosisMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Current Opinion in Lipidology|August 18, 2022
The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosisHuan Wang, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 23, 2025
The intestine and cardiovascular diseaseSamuel C Delk, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 11, 2007
The paradox of dysfunctional high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Circulation|September 25, 2003
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, Susan Hama, Greg Hough, et al.
Circulation|September 29, 2004
Genetic basis of atherosclerosis: part I: new genes and pathwaysAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Trends in Cardiovascular Medicine|August 16, 2005
The role of high-density lipoprotein in inflammationMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Current Opinion in Lipidology|July 29, 2024
Evidence further linking the intestine to cardiovascular diseaseDawoud Sulaiman, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 27, 2023
The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosisArnab Chattopadhyay, Srinivasa T Reddy, Alan M Fogelman
Nature Reviews. Nephrology|March 24, 2010
HDL metabolism and activity in chronic kidney diseaseNosratola D Vaziri, Mohamad Navab, Alan M Fogelman
Trends in Cardiovascular Medicine|March 1, 2008
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosisMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Current Opinion in Lipidology|August 18, 2022
The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosisHuan Wang, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 23, 2025
The intestine and cardiovascular diseaseSamuel C Delk, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology|July 11, 2007
The paradox of dysfunctional high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Circulation|September 25, 2003
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, Susan Hama, Greg Hough, et al.
Circulation|September 29, 2004
Genetic basis of atherosclerosis: part I: new genes and pathwaysAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Pageof 15